Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Maxil°


Not recommended
Use with caution

Not recommended
Use with caution
Maxil° :
Type Medicine Withdrawn
Originator Zinacef 750mg*
Agent Hikma-Liban
Distributor Hikma-Liban
Laboratory Hikma Pharmaceuticals
Manufacturer Hikma Pharmaceuticals PLC
Manufacturing Type G
Origin Jordan
ATC J01DC02

Your comment will appear shortly after approval

Maxil° :

Revision Date : 31/07/2015


Effect Frequency
Anaphylaxis Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Blood bilirubin increased Uncommon
Blood urea nitrogen (BUN) increased Not known
Candidiasis (Candida infection) Not known
Clostridium difficile infection Not known
Coombs direct test positive Uncommon
Creatinine renal clearance decreased Not known
Cutaneous vasculitis Not known
Drug fever Not known
Eosinophilia Common
Erythema multiforme Not known
Gastrointestinal disorders Uncommon
Haemoglobin decreased Common
Haemolytic anemia Not known
Hepatic enzyme increased Common
Injection site pain Common
Injection site reaction Common
Injection site thrombophlebitis Common
Interstitial nephritis Not known
Leucopenia (Leukopenia) Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Neutropenia Common
Pruritus Uncommon
Pseudomembranous colitis Not known
Serum creatinine increased Not known
Skin rash Uncommon
Stevens-Johnson syndrome Not known
Thrombocytopenia (Thrombopenia) Not known
Urticaria Uncommon

Different Units By MoH Code

Revision Date : 01/12/1996

Maxil°  MoH 4056 :
Form Powder for solution for injection
Packaging Bottle
Package Size Box of 1
Strength 750mg
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 24316/06
Submission date 01/01/2006
Registration Year 2007
Withdrawn Date 2017


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info